Tags: Drug.

Denileukin diftitox (trade name Ontak) is an antineoplastic agent an engineered protein combining Interleukin-2 and Diphtheria toxin. This can bind to Interleukin-2 receptors and introduce the diphtheria toxin into cells that express those receptors killing the cells. In some Leukemias and Lymphomas malignant cells express these receptors so denileukin diftitox can target these. In 1999 Ontak was approved by the U.S.

Loading...

This page contains content from the copyrighted Wikipedia article "Denileukin diftitox"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.